Centiva Capital, LP Revance Therapeutics, Inc. Put Options Transaction History

Centiva Capital, LP

  • $3.72 Billion
  • Q1 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$5.81 - $11.2 $581,000 - $1.12 Million
-100,000 Reduced 99.9%
100 $0
Q3 2023

Nov 14, 2023
BUY
$11.47 - $25.07 $574,647 - $1.26 Million
50,100 Added 100.2%
100,100 $1.15 Million
Q1 2023

May 15, 2023
BUY
$18.36 - $35.27 $918,000 - $1.76 Million
50,000 New
50,000 $1.61 Million

Others Institutions Holding RVNC

# of Institutions
214
Shares Held
83.4M
Call Options Held
656K
Put Options Held
424K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email